BRAIN AG

EFIB Stakeholder Profile​

Company/Organisation type: SME

Focus area/active in: 

  • Bio-based Chemistry
  • Enzyme Technologies & Bioprocesses
  • Animal Feed & Additives
  • Fuels / Lubricants
  • Personal Care (e.g. cosmetics)
  • Strain Development
  • Synthetic Biology

About:

B.R.A.I.N. Biotechnology Research and Information Network AG (BRAIN AG) is one of Europe’s leading technology companies in the field of industrial biotechnology, the core discipline of the bioeconomy. As such, BRAIN identifies previously untapped efficient enzymes, microbial producer organisms or natural substances from complex biological systems that can be put to industrial use. The innovative solutions and products developed by means of “Nature’s Toolbox” are successfully applied in the chemicals, cosmetics and food industries. BRAIN’s business model is based on two pillars. The BioScience segment mainly comprises research and development business with industrial partners, and the company’s own research and development. The BioIndustrial segment consists mainly of business with industrially scalable products. As part of a growth-oriented industrialization strategy, BRAIN AG has been listed on the Prime Standard of the Frankfurt Stock Exchange since February 2016 as the first company in the bioeconomy.

Website: www.brain-biotech.com

Follow us:

Advance your business

Find examples of our products and solutions in the field of nutrition, health and environment.

Get in touch!

Dr. Martin Langer
EVP, Head Business Development
BRAIN AG

Please fill out the form below to get in touch with us.